Plenary Speech, TCM Kongress Rothenburg 2015, 14.05.2015
Dr. Andrea Hellwig, President of the AGTCM
Good morning fellow colleagues and most welcomed guests of the TCM Kongress Rothenburg 2015, today I would like to talk about perspectives and paradigms about obstacles and opportunities. How western science and western medicine see the world - their perspective and the set of ideas they use to understand and explain that world - this paradigm will greatly effect the success of western medicine and western healthcare systems.
How many of you out there, agree we are faced with a medical crisis in the western world? Dr. Sean Murphy described this crisis and the challenges our European healthcare system faces at the ETCMA general assembly in Prague this year:
He said, "The rates of common diseases, such as diabetes, overweight and obesity, cardiovascular disease, cancer, etc. in European countries, are increasing dramatically, the patient's satisfaction with conventional medical care is decreasing and at the same time, we are looking at a future with steadily increasing health care costs. "
We are in a medical crisis.
And I would like to talk about the real roots of the crisis, the true core from what our healthcare systems and our understanding of adaequate health-care is suffering itself and how this problem could be solved...
Continue Reading the PDF
May 11 2015 - Press release - The Kooperation deutscher Tierheilpraktikerverbände
The European Commission has tabled a proposal to amend or, to be more precise, replace the existing law on veterinary medicinal products (Proposal for a Regulation of the European Parliament and of the Council on veterinary medicinal products /* COM/2014/0558 final - 2014/0257 (COD) */). Because of the variety of animal species, the legal regulation of veterinary medicinal products is very piecemeal. This has resulted in a variety of supplementary regulations and provisions that render the law very unwieldy and in some respects contradict the rules and objectives of the internal market.
The Kooperation deutscher Tierheilpraktikerverbände, which is an umbrella organization of five professional associations of CAM animal practitioners in Germany, the Fachverband Niedergelassener Tierheilpraktiker and the Ältester Verband der Tierheilpraktiker Deutschlands, issued a joint statement to this proposal:
CAM (Complementary and Alternative Medicine) animal practitioners/Tierheilpraktiker regard themselves as members of a regulated animal health profession. The activities of CAM animal practitioners in Germany are governed by several laws and provisions. In this context, the position of CAM animal practioners is that the reorganization of the veterinary medicinal products legislation and the following core objectives are completely welcome, namely,
Press release from May 4th 2015 — La Fédération de la médecine complémentaire Fedmedcom
On April 28 2015 the State Secretary for Education, Research and Innovation (SBFI) approved the advanced professional examination for Naturopaths.This ensures the nationally- recognised and protected title: Naturopathic practitioner with Advanced Federal Diploma of Professional Education and Training.
The profession recognizes four specific therapeutic fields: Ayurvedic Medicine, Homeopathy, Traditional Chinese Medicine (TCM) and Traditional European Naturopathy (TEN). Thus,a core requirement of the constitutional article 118a for the establishment of national diplomas for non-medical professions in the field of complementary medicine is fulfilled.
by the PHARMACEUTICAL COMMITTEE of the EU-Commission (Health systems and products- Medicinal products – authorizations, European Medicines Agency) in relation to the Matrix-Report of 2012, referring to the Herbal aspect.
By Nora Laubstein (inspired by Dr. Mathias Schmidt and Dr. Hubert Schwabl)
The summary of comments about the Matrix report gives a fairly good overview about the regulatory difficulties of herbal medicinal products. But in the report a rather neutral position prevails.
An example - Looking back in German Herbal Medicines history:
Practically all of the registrations mentioned in the report for Germany are NOT new products or switches from food supplement to drug status; they are generally products that existed for many years as authorized herbal medicinal products.
ECHAMP warmly welcomes the publication of the ‘External Study Report on the Availability of Medicinal Products for Human Use,’ which gives significant prominence, for the first time, to the situation concerning the availability of homeopathic and anthroposophic medicinal products in the EU. Although the report contains some statements that are not fully correct from ECHAMP's point of view, the overall positive aspects clearly outweigh the deficits.
The long-awaited study investigates the availability of medicinal products for human use in the EU and EEA, focusing on the authorisation procedures for medicinal products. It investigates different reasons for lack of availability and the effectiveness of existing European legislative provisions in addressing these problems, exploring six case studies, including the use of Article 126a of Directive 2001/83/EC (Cyprus Clause) and the availability of herbal, homeopathic and anthroposophic medicinal products.
The study quotes ECHAMP’s own report ‘The Availability of Homeopathic and Anthroposophic Medicinal Products in the EU’ as its main source of information on this topic. ECHAMP is now working hard to analyse the new report and we will share our conclusions with Members before Christmas. For now, we welcome the fact that the report acknowledges the need to improve the national implementation of simplified procedures for homeopathic and anthroposophic medicinal products as one example of a specific area for improvement.
This study report is presented as a working document of the Pharmaceutical committee, an advisory Committee to the Commission that consists of senior experts in public health matters from the Member States' administrations; it is an independently written document, which means it does not necessarily reflect the official opinion of the European Commission. Nevertheless, it is hoped it will add significant weight to ECHAMP’s goal of suitable regulation for our products.